Michael Stein, PhD
Dr. Michael Stein is the CEO of Valo Therapeutics, a developer of novel cancer immunotherapies with a unique approach to delivering a highly immunogenic and rapidly adaptable tumor vaccination platform. Dr. Stein is a business leader and strategic advisor with C-suite experience in healthcare. Prior to joining Valo TX, Michael was the founding CEO of OxStem, an award-winning biotechnology spin-out from the University of Oxford, which broke the UK record for a seed round fund-raise. In addition, Michael has served as the founding CEO for Doctor Care Anywhere, acquired by Synergix. In 2001, he co-founded the Map of Medicine with University College London. As founding CEO, and later CMO, the Map was nationally licensed across NHS England and acquired by Hearst Business Media, after which Michael transitioned to executive vice-president of healthcare innovation. Michael graduated from the University of Cape Town as a medical doctor with Honours and biochemist with First Class Honours, and from the University of Oxford as a Rhodes Scholar with a doctorate in Physiological Sciences, Immunology. He subsequently was appointed as a Junior Research Fellow in Medicine at Trinity College, Oxford, subsequently lecturing part-time in Immunology and Pathology at Balliol College, Oxford. As a medical scientist, Michael first described the alternative pathway of macrophage activation. In addition, he has co-authored the best-selling UK medical handbook.